APVO compared with BNGO: revenue, margins and what each company keeps, and the suppliers and customers both name

APVOAptevo Therapeutics Inc.

Mkt capRevenueRevenue

BNGOBionano Genomics, Inc.

Mkt capRevenueRevenue

Compare

APVOAptevo Therapeutics Inc.

BNGOBionano Genomics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

APVO: latest quarter not drawable. BNGO: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

APVO, solidBNGO, dashed

APVOAptevo Therapeutics Inc.

1.31▼−3.68%· post 1.41

Mkt cap$2.4MRevenue—Revenue—

BNGOBionano Genomics, Inc.

1.15▼−4.17%· post 1.18

ClosedOct 30 '26

Mkt cap$13.5MRevenue$8MQ2 FY26Revenue$29MFY25

Compare

ClosedOct 30 '26

APVOAptevo Therapeutics Inc.

BNGOBionano Genomics, Inc.

1.31▼−3.68%post 1.41

Price

1.15▼−4.17%post 1.18

$2.4M

Mkt cap

$13.5M

—

Revenue

$8MQ2 FY26

—

Revenue

$29MFY25

APVO1.31▼−3.68%vsBNGO1.15▼−4.17%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only APVO 2

—Alligator Bioscience ABunlistedsupplier

—Open Monoclonal Technologyunlistedsupplier

Shared 0

No disclosed counterparties: BNGO.

Only BNGO 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR